Using CT scans to find salvageable bowel in mesenteric ischemia
Part of Digestive system, Heart & circulation clinical trials.
This trial is testing a new way to use CT scans to identify which parts of the bowel can still be saved in patients with acute mesenteric ischemia. It aims to help doctors make better decisions about whether surgery is needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are already signed up for the AMESI study.
- You have confirmed or suspected acute mesenteric ischemia (sudden loss of blood flow to your intestines).
- You have a CT scan of your whole abdomen (or entire body) that was done with intravenous contrast dye.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is looking for biomarkers (clues in your blood) that can help doctors predict acute mesenteric ischemia, a condition where blood flow to your gut is suddenly blocked. It may help find better ways to diagnose this serious condition early.
This study is looking for signs in the body (called biomarkers) after sudden loss of blood flow to the intestines. It involves getting a CT scan to check what is happening in the abdomen so the researchers can see which signals match intestinal injury.
This pilot study looks at markers in your blood that might help doctors tell if you have a serious bowel condition called acute mesenteric ischemia. You may be asked to participate if you have severe belly pain and need a special CT scan to check for this condition.
This trial tests whether taking oral antibiotics (gentamicin and metronidazole) can treat acute mesenteric ischemia caused by an artery blockage, instead of using IV antibiotics. It's for people who don't need emergency surgery and don't have a serious infection.
This study looks at how acute mesenteric ischemia (a condition where blood flow to the intestine is suddenly reduced) and its treatment affect quality of life. It aims to understand the long-term effects on patients treated between 2010 and 2022.
This study looks at ways to promote early diagnosis of chronic mesenteric ischemia, a condition where the intestines don’t get enough blood over time. If you’re being evaluated for this problem, the trial may help ensure the right diagnosis happens sooner.
Hear when a new Acute Mesenteric Ischemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.